Related Experiment Video
Updated: Jan 22, 2026
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma
Makoto Adachi1, Caixia Cui, Cristina T Dodge
1Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Objectives:
Signal transducer and activator of transcription 3 (STAT3) has been implicated in the development and progression of various solid tumors. We examined the efficacy of STAT3 inhibition as a novel therapeutic option for head and neck squamous cell carcinoma (HNSCC).
Materials And Methods:
Activation and expression of STAT3 and hypoxia-inducible factor-1α (HIF-1α) in HNSCC cell lines were assessed by immunoblots. The small molecule inhibitor, Stattic, was used to target STAT3 in HNSCC cell lines. MTT assays were performed to determine the effect of STAT3 inhibition on HNSCC cell viability, while clonogenic survival assays were used to assess the ability of Stattic to sensitize HNSCC cells to radiation therapy. We also examined the effect of Stattic on tumor growth and radiosensitivity in vivo using an orthotopic xenograft model of HNSCC.
Results:
Stattic effectively inhibited STAT3 activation and expression, resulting in decreased cell survival and proliferation and increased radiosensitivity. STAT3-mediated HIF-1α expression was also reduced in response to Stattic treatment. Oral administration of Stattic significantly reduced the growth of HNSCC tumors in a murine orthotopic xenograft, and analysis of tumor lysates confirmed decreased STAT3 phosphorylation.
Conclusion:
STAT3 inhibition modulates HIF-1α expression, resulting in decreased tumor growth and possible enhanced radiosensitivity in HNSCC. Our results provide support for further exploration of STAT3 as a novel molecular therapeutic target in HNSCC.
Insights
Inhibiting Signal transducer and activator of transcription 3 (STAT3) with Stattic reduced head and neck squamous cell carcinoma (HNSCC) growth and enhanced radiation sensitivity. This suggests STAT3 is a promising therapeutic target for HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Signal transducer and activator of transcription 3 (STAT3) plays a role in various solid tumor development and progression.
- STAT3 signaling is a potential therapeutic target for head and neck squamous cell carcinoma (HNSCC).
Purpose of the Study:
- To investigate the efficacy of STAT3 inhibition as a novel therapeutic strategy for HNSCC.
- To evaluate the impact of STAT3 inhibition on HNSCC cell viability, proliferation, and radiosensitivity.
Main Methods:
- Assessed STAT3 and hypoxia-inducible factor-1α (HIF-1α) expression in HNSCC cell lines using immunoblots.
- Utilized the small molecule inhibitor Stattic to target STAT3 in HNSCC cell lines.
- Performed MTT assays, clonogenic survival assays, and an in vivo orthotopic xenograft model to evaluate Stattic's effects on tumor growth and radiosensitivity.
Main Results:
- Stattic effectively inhibited STAT3 activation and expression, leading to reduced HNSCC cell survival and proliferation.
- STAT3 inhibition with Stattic increased HNSCC cell radiosensitivity and decreased STAT3-mediated HIF-1α expression.
- Oral administration of Stattic significantly inhibited HNSCC tumor growth in vivo, with decreased STAT3 phosphorylation observed in tumor lysates.
Conclusions:
- STAT3 inhibition, by modulating HIF-1α expression, reduces tumor growth and enhances radiosensitivity in HNSCC.
- STAT3 represents a promising molecular therapeutic target for HNSCC, warranting further investigation.
Related Concept Videos
01:30Enzyme Inhibition
01:26Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
01:19Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
00:46Feedback Inhibition
01:26Muscles of the Anterior Neck
01:19Muscles that Move the Head
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...